ISOBM AWARDS
The Abbott Award
The ISOBM Abbott Award, awarded annually to a scientist, not necessarily a Society member, who has made an outstanding contribution to the field of basic or clinical oncology, has been made possible by a generous gift from the Abbott Laboratories.
 |
ISOBM and Abbott are pleased to announce that
Herbert A. Fritsche , PhD
Professor (Retired), MD Anderson Cancer Center, University of Texas
is the recipient of the ISOBM Abbott Award for 2015.
The ISOBM Abbott Award Ceremony and Lecture
will take place on Monday, 5th of October |
Dr. Herbert Fritsche is a native of Houston, Texas. He received a B.S. in Chemistry (Univ of Houston, 1963), and M.S. (1965) and Ph.D. degrees (1968) in Chemistry from Texas A & M Univ. From 1967 to 1969, he served on active duty in the US Army, as Captain and Assistant Chief, Clinical Chemistry Section, First U.S. Army Medical Laboratory in Ft. Meade, MD. In 1969, he accepted the position as Chief of Clinical Chemistry at M. D. Anderson Cancer Center. In that capacity, Dr. Fritsche directed the clinical chemistry testing operations for the MD Anderson Hospital and outpatient clinics; directed the education of medical fellows, pathology residents, graduate students (University of Texas Graduate School of Biomedical Sciences) and medical technology students (University of Texas School of Allied Health Sciences); and conducted an active translational research program in the development and validation of cancer diagnostics and their implementation in routine clinical practice.
He is an active member of the American Association for Clinical Chemistry since 1968, and has served in all elected and appointed positions of the Texas Section AACC, chaired the National Education Committee and the Education Committee of the Immunology Division of the AACC. Dr Fritsche is a Fellow in the National Academy of Clinical Biochemistry (NACB). He has served on many of the committees of the AACC and the NACB, and numerous grant review committees for the National Cancer Institute. He is a long time member of the ISOBM, and has served as National President of both the Clinical Ligand Assay Society, and the Texas Medical Center Chapter of Sigma Xi. Currently, he is a member of the editorial board of six journals, a founding member of the Tumor Marker Expert Panel (American Society of Clinical Oncology) and the Tumor Marker Guidelines Committee for (NACB), he has served as a consultant to the Technology Expert Panel for Blue Cross Blue Shield and the US FDA, and to numerous diagnostic companies.
Dr Fritsche is the recipient of the 1979 Outstanding Clinical Chemist Award from the Texas Section-AACC, the 1992 National AACC Award for Outstanding Contributions in Education, the 1997 Johnson and Johnson Award for Outstanding Research from the NACB, the CLAS Distinguished Scientist Award in 1999, the 2006 Morton K Schwartz AACC Award for Significant Contributions in Cancer Research Diagnostics, and in 2011, he received the Morton K Schwartz Lectureship Award from the New York Metro Section of the AACC. He has lectured at many international meetings and has published more than 180 manuscripts and 30 book chapters in the field of cancer diagnostics. He holds four patents, is the co-author of a textbook on Tumor Markers, published by AACC press, and he served as the Meeting Director of Conferences on Cancer Diagnostics held in 1999, 2001, 2003 and 2006, all of which were approved programs offered under the sponsorship of the M. D. Anderson Cancer Center. In Aug, 2010, after 41 years of service, Dr Fritsche retired from the University of Texas MD Anderson Cancer Center as Professor, Full Biochemist, Chief Clinical Chemistry and Full Member of the Graduate Faculty of the Graduate School of Biomedical Sciences.
In Sept, 2010, Dr Fritsche accepted a position as Senior Vice President, Chief Science Officer and Member of the Board of Directors for Health Discovery Corporation,Savannah, GA (2010-2012), and then continued as senior consultant until Jan, 2013. He is currently serving as a consultant to the medical diagnostics industry (Siemens, EDP, IR2DX, Onconexus) and to the Charles University in Prague, Czech Republic, Medical School in Plzen. In Feb, 2014 Dr Fritsche was appointed by Vermillion Corp to be the Director of Aspira Laboratory, a CLIA certified testing facility located in Austin, TX, which offers diagnostic test services for women’s health
The former ISOBM ABBOTT AWARD WINNERS
| 2014 |
Ken Yamaguchi |
(Shizuoka) |
|
2000 |
Luciano Zardi |
(Genova) |
| 2012 |
Joe M. Duffy |
(Dublin) |
|
1999 |
Nicole Beauchemin |
(Montreal) |
| 2011 |
Petra Stieber |
(Munich) |
|
1999 |
John Thompson |
(Freiburg) |
| 2010 |
Rolf Lamerz |
(Munich) |
|
1999 |
Hiroshi Nakazato |
|
| 2009 |
Torgny Stigbrand |
(Umeå) |
|
1999 |
John Shively |
(City of Hope) |
| 2008 |
Kazuhisa Taketa |
(Ibara) |
|
1998 |
Sten Hammarström |
(Umea) |
| 2007 |
Stewart Sell |
(New York) |
|
1998 |
Shinzo Nishi |
(Sapporo) |
| 2006 |
Ron Levy |
(Stanford) |
|
1997 |
Markku Seppala |
(Helsinki) |
| 2005 |
Kohzoh Imai |
(Sapporo) |
|
1997 |
Hans Bohn |
(Marburg) |
| 2004 |
Timothy J. o'Brien |
(Little Rock) |
|
1997 |
Yuri Tatarinov |
(Moscow) |
| 2003 |
Richard Begent |
(London) |
|
1996 |
Tsan Ming Chu |
(Buffalo) |
| 2003 |
Kerry Chester |
(London) |
|
1995 |
Erriki Ruoslahti |
(La Jolla) |
| 2002 |
Elefrherios Diamandis |
(Toronto) |
|
1994 |
David Goldenberg |
(Newark) |
| 2002 |
Ulf-Hakan Stenman |
(Helsinki) |
|
1994 |
Jean-Pierre Mach |
(Lausanne) |
| 2002 |
Hans Lilja |
(Lund) |
|
1993 |
Bill Fishman |
(San Diego) |
| 2001 |
Robert C. Bast Jr. |
(Houston) |
|
1992 |
Phil Gold |
(Montreal) |
| 2001 |
Kenneth O. Loyd |
(New York) |
|
1991 |
Gary Abelev |
(Moscow) |
| 2000 |
Dario Neri |
(Zürich) |
|
1990 |
Sabine von Kleist |
(Freiburg) |
Fellows and Junior Faculty: Merit Awards
The ISOBM offers 5 Merit Awards of 1000 Euro each, to students and young scientists (≤ 35 years of age), who submit and present high-quality abstracts.
The Merit Award will be bestowed to the awardees during closing ceremony, on 7th of October.
Merit Award candidates must apply for this award at the time of abstract submission.
The First Author (the presenter) must meet all of the following requirements to be considered for a Merit Award:
• Work in a cancer research laboratory, or a clinical research setting, or any other life science department.
• Provide a letter of agreement to present the abstract at the ISOBM Congress and publish it on the ISOBM website.
• Provide a letter of award request, with an up to two-page Curriculum Vitae including date of birth.
The above indicated letters with a copy of the abstract should be sent by email to bozena.chowaniec@trip.pl
The ISOBM Board and ISOBM Award Committee presented the ISOBM Young Scientist Merit Awards to:
Esther Arnaiz (Vitoria-Gasteiz, Spain)
for “Exploring Exosomal Urinary miRNAs for Bladder Cancer Diagnostics”
Anna M. Czarnecka (Warsaw, Poland)
for “Gene Expression Signature of Cancer Stem Cells in Renal Cell Cancer”
Andrii Dinets (Stockholm, Sweden)
for “Identification of Preoperative Diagnostic Markers for Discrimination between Benign and Malignant Thyroid Cysts by a Proteomic Approach”
Marcin Nicoś (Lublin, Poland)
for “Analysis of Driver Mutations Incidence in Central Nervous System Metastatic Lesions of Non-Small-Cell Lung Cancer”
Samanta Salvi (Meldola, Italy)
for “Copy Number Variations of AR Gene in Serum Circulating Cell-Free DNA as Biomarker Predicting Outcome in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide”
EGTM AWARD
The EGTM will grant the 2015 EGTM AWARD for a Tumor Marker study, during the EGTM session at the ISOBM 2015
The EGTM Board and the EGTM Award Committee presented the EGTM Young Scientist Merit Award to Ondrej Fiala (Pilzen, Czech Republic) for “Predictive and Prognostic Role of Serum Tumor Markers in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab”
.jpg)
.jpg)
.jpg)
.jpg)
